Isn’t It Time for Equity Between Hemophilia and VWD?

Dr. Dawn Goodyear critically compares standards of care between hemophilia and von Willebrand disease (VWD), focusing on the disparity in long-term prophylaxis use. She discusses epidemiology, disease burden (especially in women), and gaps in diagnosis and treatment equity, referencing guidelines and emerging evidence for broader prophylaxis in severe VWD. The lecture frames the need for more proactive, individualized management and addresses pressing research questions—making this relevant for advancing best practices in bleeding disorder care.